Isochromosome 12p

From Libre Pathology
Revision as of 16:10, 31 October 2023 by Michael (talk | contribs) (typo)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Schematic description of an isochromosome (Kazulanth/WC).

Isochromosome 12p, abbreviated i(12p), a genetic abnormality associated with germ cell tumours.[1]

i(12p) is seen in approximately 80% of male germ cell tumours.[2]

Can be detected with NGS and/or FISH.[3][4]

See also

References

  1. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S (June 2021). "Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing". Hum Pathol 112: 20–34. doi:10.1016/j.humpath.2021.03.008. PMID 33798590.
  2. Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RS (March 1994). "Clinical relevance of the i(12p) marker chromosome in germ cell tumors". J Natl Cancer Inst 86 (5): 349–55. doi:10.1093/jnci/86.5.349. PMID 8308927.
  3. Fichtner A, Richter A, Filmar S, Gaisa NT, Schweyer S, Reis H, Nettersheim D, Oing C, Gayer FA, Leha A, Küffer S, Ströbel P, Kaulfuß S, Bremmer F (March 2021). "The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reaction". Histopathology 78 (4): 593–606. doi:10.1111/his.14258. PMID 32970854.
  4. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S (June 2021). "Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing". Hum Pathol 112: 20–34. doi:10.1016/j.humpath.2021.03.008. PMID 33798590.